Name: Benlysta - BULK PURCHASE | MOQ 10 CARTONS
SKU: gsk-0000009
Availability: InStock

One Africa-One Market - Your Borderless B2B Sourcing Portal

Become a Merchant

Kenyan Products

Benlysta - BULK PURCHASE | MOQ 10 CARTONS

التوفر:

في الأوراق المالية

حالة:

New

أضف إلى قائمة الامنيات

طلب اقتباس

تم بيعها من قبل نظرة سريعة

Kenyan Products

Kenya

مفتاح الميزات

MOQ 10 CARTONS
Disease-Modifying: Belimumab is designed to reduce the activity of systemic lupus erythematosus (SLE) by inhibiting B-cell activating factor (BAFF), a protein that promotes the survival of B cells involved in autoimmune responses.
Improves Symptoms: Helps to decrease disease activity, reduce symptoms, and improve overall quality of life for patients with SLE.
Flexible Administration: Available in both intravenous (IV) and subcutaneous (SC) forms, allowing for different treatment options based on patient needs and preferences.

اشترى في كثير من الأحيان جنبا إلى جنب:

BENLYSTA is the first medicine approved to treat systemic lupus and adults with active lupus nephritis, an important treatment advance

تفاصيل تقنية:

UPC:	gsk-0000009
رمز SKU للبائع:	gsk-0000009
حالة:	New
التوفر:	في الأوراق المالية
أقل كمية ممكن طلبها:	10
التاريخ المدرج لأول مرة على Zandaux:	Aug 30, 2024

BENLYSTA is the first medicine approved to treat systemic lupus and adults with active lupus nephritis, an important treatment advance

PRODUCT DESCRIPTION:

Disease-Modifying: Belimumab is designed to reduce the activity of systemic lupus erythematosus (SLE) by inhibiting B-cell activating factor (BAFF), a protein that promotes the survival of B cells involved in autoimmune responses.

Improves Symptoms: Helps to decrease disease activity, reduce symptoms, and improve overall quality of life for patients with SLE.

Flexible Administration: Available in both intravenous (IV) and subcutaneous (SC) forms, allowing for different treatment options based on patient needs and preferences.

لم يتم تقديم تعليقات